Korro Bio

KRRO NASDAQ IPO2023

about KRRO

Korro Bio is a biotechnology company focused on developing innovative biologic therapies targeting diseases with significant unmet medical needs.

type open high low market
cap
volume
stock $6.82 $7.24 $6.73 $66.11M 602.08K
eps price to
earnings
price to
sales
operating
margin
profit
margin
yield
-$1.92 n/a 62.04 -1764.86% -1656.97% 0%